The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: Study rationale and design
- 30 April 2007
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 153 (4) , 478-484
- https://doi.org/10.1016/j.ahj.2007.02.004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Death in Heart FailureCirculation, 2006
- Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart FailureCirculation, 2006
- Potential Applications of Outpatient Nesiritide Infusions in Patients With Advanced Heart Failure and Concomitant Renal Insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] Trial)The American Journal of Cardiology, 2006
- Short-term Risk of Death After Treatment With Nesiritide for Decompensated Heart FailureJAMA, 2005
- Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart FailureCirculation, 2005
- Treatment with B-Type Natriuretic Peptide for Chronic Decompensated Heart Failure: Insights Learned from the Follow-Up Serial Infusion of Nesiritide (FUSION) TrialHeart Failure Reviews, 2005
- Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)The American Journal of Cardiology, 2004
- BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular DiseasesCongestive Heart Failure, 2004
- Preferences for quality of life or survival expressed by patients with heart failureThe Journal of Heart and Lung Transplantation, 2001
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987